Methylation analysis as an auxiliary tool in cytological diagnostics of infrequent anogenital lesions - a pilot study

Česká verzia

Authors: Jana Němcová ^1,2,3; Kateřina Černá ^1,2,3; Radek Šíma ²; Iva Kinkorová Luňáčková ²; Filip Rob ⁵; Petr Martínek ²; Jiří Bouda ⁶; Jana; Šmahelová ⁴; Ondrej Ondič ^1,2,3
Authors place of work: Šiklův ústav patologie, FN Plzeň ¹; Bioptická laboratoř, Plzeň ²; Biomedicínské centrum lékařské fakulty v Plzni, Plzeň ³; Katedra genetiky a mikrobiologie, PřF Univerzity Karlovy, Biocev, Vestec ⁴; Dermatovenerologické oddělení 2. LF Karlovy univerzity v Praze a nemocnice Na Bulovce, Praha ⁵; Gynekologicko-porodnická klinika LF UK a FN Plzeň, Plzeň ⁶
Published in the journal: Čes.-slov. Patol., 59, 2023, No. 1, p. 26-31
Category: Original Articles

Summary

Methylation silencing of certain cellular genes is a sign of carcinogenesis progression and therefore tests that detect methylation could be used in the diagnosis or staging of malignant diseases. In the diagnosis of squamous cell carcinomas of the cervix which are almost 100% caused by long-term infection with highrisk human papillomavirus (HR-HPV), methylation silencing of certain cellular genes is a highly specific marker of advanced dysplastic lesions and appears to result from aberrant activation of the methyltransferase DNMT1 by viral oncoproteins E6 and E7. A methylation test performed on a cervicovaginal cytology specimen allows to increase the diagnostic value of this non-invasive test and to select patients with severe squamous cell lesions for follow-up. Other less frequent anogenital malignancies that are induced by HR-HPV to a lesser extent can also be detected by cytological examination - glandular lesions of various origins, most commonly cervical and endometrial adenocarcinomas and anal carcinoma. The aim of our pilot study was to evaluate the utility of a methylation test for the diagnosis of these malignancies in a cohort of 50 liquid-based cervicovaginal cytologies with glandular lesion and 74 liquid-based anal cytologies from HIV-positive men having sex with men who are at high risk for anal cancer development.

Keywords:

cytology – Methylation – HR-HPV – glandular lesions – anal carcinoma

Zdroje

1. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the european union. Eur J Cancer 2009; 45(15): 2640-2648.

2. Cuzick J, Bergeron C, Von Knebel Doeberitz M, et al. New technologies and procedures for cervical cancer screening. Vaccine 2012; 30 Suppl 5: F107-116.

3. Kinkorová Luňáčková I, Majek O. Karcinom děložního hrdla v ČR a možnosti jeho prevence. Cesk Patol 2018; 63(4): 164-168.

4. Dijkstra MG, Snijders PJ, Arbyn M, et al. Cervical cancer screening: On the way to a shift from cytology to full molecular screening. Ann Oncol 2014; 25(5): 927-935.

5. Černá K, Němcová J. Molekulárně genetické metody ve skríningu karcinomu děložního hrdla. Cesk Patol 2018; 63(4): 169-174.

6. Lorincz AT, Brentnall AR, Scibior-Bentkowska D, et al. Validation of a DNA methylation HPV triage classifier in a screening sample. Int J Cancer 2016; 138(11): 2745-2751.

7. de Strooper LMA, Verhoef VMJ, Berkhof J, et al. Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women. Gynecol Oncol 2016; 141(2): 341-347.

8. Chen ZX, Riggs AD. DNA methylation and demethylation in mammals. J Biol Chem 2011; 286(21): 18347-18353.

9. Holčáková J. Vliv metylace DNA na vznik nádorových onemocnění. Klin Onkol 2018; 31(Suppl 2): 41-45.

10. Fernandez AF, Rosales C, Lopez-Nieva P, et al. The dynamic DNA methylomes of double- stranded DNA viruses associated with human cancer. Genome Res 2009; 19(3): 438-451.

11. Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014; 14(6): 395-405.

12. Kremer WW, Steenbergen R, Heideman D, Kenter GG, Meijer C. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: A review. BJOG 2021; 128(3): 504-514.

13. Ondič O, Němcová J, Alaghehbandan R, et al. The newly proposed international endocervical adenocarcinoma criteria and classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases. Cytopathology 2020; 31(4): 288-291.

14. Yoshida H, Shiraishi K, Kato T. Molecular pathology of human papilloma virus-negative cervical cancers. Cancers (Basel) 2021; 13(24): 6351. doi:10.3390/cancers13246351

15. de Strooper LM, Van Zummeren M, Steenbergen RD, et al. CADM1, MAL and mir124- 2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. J Clin Pathol 2014; 67(12): 1067-1071.

16. Vink FJ, Meijer C, Clifford GM, et al. FAM19A4/ mir124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study. Int J Cancer 2020; 147(4): 1215-1221.

17. Siegenbeek Van Heukelom ML, Marra E, De Vries HJC, Schim Van Der Loeff MF, Prins JM. Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: Is targeted screening possible? AIDS 2017; 31(16): 2295-2301.

18. Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54(7): 1026-1034.

19. Rob F, Němcová J, Šmahelová J, Marx J, Ondič O. Anální karcinom a jeho screening. Čes-slov Derm 2022; 97(1): 3-11.

20. Němcová J, Černá K, Rob F, et al. Prevalence of high-risk human papillomavirus DNA and mRNA and its association with abnormal anal cytology in the Czech male anal cancer screening cohort. Diagn Cytopathol 2021; 49(11): 1188-1195.

21. Tieben LM, Ter Schegget J, Minnaar RP, et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42(2-3): 265-279.

22. de Strooper LMA, Berkhof J, Steenbergen RDM, et al. Cervical cancer risk in HPV-positive women after a negative FAM19A4/ mir124-2 methylation test: A post hoc analysis in the Pobascam trial with 14 year follow- up. Int J Cancer 2018; 143(6): 1541-1548.

23. Louvanto K, Aro K, Nedjai B, et al. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clin Infect Dis 2020; 70(12): 2582-2590.

24. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science. Gynecol Oncol 2009; 112(2): 293-299.

25. Bonde J, Floore A, Ejegod D, et al. Methylation markers FAM19A4 and mir124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study. Int J Cancer 2021; 148(2): 396-405.

26. Dick S, Kremer WW, De Strooper LMA, et al. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/mir124-2 methylation analysis. Gynecol Oncol 2019; 154(2): 368- 373.

27. Clifford GM, Alberts CJ. Molecular risk stratification for anal cancer prevention. Clin Infect Dis 2021; 72(12): 2164-2166.

28. Leeds IL, Fang SH. Anal cancer and intraepithelial neoplasia screening: A review. World J Gastrointest Surg 2016; 8(1): 41-51.

29. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta- analysis. Lancet Oncol 2012; 13(5): 487-500.

30. Berry JM, Jay N, Cranston RD, et al. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer 2014; 134(5): 1147-1155.

31. Lee JY, Lensing SY, Berry-Lawhorn JM, et al. Design of the ANal Cancer/HSIL outcomes research study (ANCHOR study): A randomized study to prevent anal cancer among persons living with HIV. Contemp Clin Trials 2022; 113: 106679. :106679. doi: 10.1016/j.cct.2022.

32. Clarke MA, Wentzensen N. Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers. Cancer Cytopathol 2018; 126(7): 447-460.

33. Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: A systematic review and meta-analysis. Lancet Infect Dis 2018; 18(2): 198-206.

34. Hernandez JM, Siegel EM, Riggs B, et al. DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One 2012; 7(11): e50533.

35. Van Der Zee RP, Van Noesel CJM, Martin I, et al. DNA methylation markers have universal prognostic value for anal cancer risk in hiv-negative and hiv-positive individuals. Mol Oncol 2021; 15(11): 3024-3036.

36. Lorincz AT, Nathan M, Reuter C, et al. Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions. Oncotarget 2017; 8(31): 50510-50520.

37. Lahiri CD, Nguyen ML, Mehta CC, et al. Pilot study of markers for high-grade anal dysplasia in a southern cohort from the women’s interagency human immunodeficiency virus study. Clin Infect Dis 2020; 70(6): 1121-1128.

38. Arumugam T, Ramphal U, Adimulam T, Chinniah R, Ramsuran V. Deciphering DNA methylation in HIV infection. Front Immunol 2021; 12:795121. doi:10.3389/fimmu.2021.795121.